Return to Article Details NLRX1 ligand, docosahexaenoic acid, ameliorates LPS-induced inflammatory hyperalgesia by decreasing TRAF6/IKK/IkB-a/NF-kB signaling pathway activity Download Download PDF
Themes by Openjournaltheme.com Themes by Openjournaltheme.com